Mitchell P. Kopin 13D and 13G filings for Kintara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-29 07:00 am Purchase | 2020-12-31 | 13G | Kintara Therapeutics, Inc. KTRA | Mitchell P. Kopin | 514 3.500% | 514 (New Position) | Filing |